Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 5, 2022 | Series A | — | 1 | — | — | Detail |
Mar 22, 2022 | Series A | $45M | 3 | Milano Investment Partners SGR | — | Detail |
Jan 1, 2022 | Convertable Note | $10M | 1 | Alameda Research | — | Detail |
Sep 30, 2021 | Series A | — | 1 | — | — | Detail |
Mar 20, 2020 | Convertable Note | $110K | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Milano Investment Partners SGR | Yes | Series A |
Alameda Research | Yes | Convertable Note |
Yes VC | — | Series A |
Bill Silva Ventures | — | Series A |
Odesangel AB | — | Convertable Note |
Starlight Ventures | — | Convertable Note |
Todd Tweedy | — | Convertable Note |
George Ruan | — | Convertable Note |
Hopper-Dean Investors | — | Convertable Note |
Marstar Alternative Investments | — | Convertable Note |